Just another angle - which prove to be absolutely wrong. Novosorb is proven to support the healing of burns and other wounds at the dermis level. Many people in hospitals (or requiring home care and key medical expertise) is for the treatment of recalcitrant wounds. Is there a chance to free up this expertise by accelerating wound repatriation via Novosorb?
I know this may be a stretch, (and looking for an upside here) however I do think most of the general public do not understand how recalcitrant and problematic wounds are. Is this a possible accelerant for uptake of Novosorb in order to free up beds/personnel/key resources?
Coronavirus Fears, page-3
-
- There are more pages in this discussion • 321 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.56 |
Change
-0.110(4.12%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.62 | $2.53 | $1.942M | 757.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 6962 | $2.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.57 | 20033 | 16 |
View Market Depth
| Last trade - 11.18am 25/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |